GlaxoSmithKline.
GSK.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
GlaxoSmithKline (GSK) is a global biopharmaceutical company that researches, develops, and manufactures innovative medicines, vaccines, and consumer healthcare products. Its pharmaceuticals segment focuses on developing and marketing prescription medicines for a range of therapeutic areas, including...Show More
Better Health for All
20
GSK's core business is focused on developing and manufacturing innovative medicines, vaccines, and consumer healthcare products for various therapeutic areas, including respiratory diseases, HIV, oncology, immunology, influenza, meningitis, and childhood illnesses. Specific products mentioned include the RTS,S malaria vaccine, Arexvy RSV vaccine, and Linerixibat. There is no evidence of products with negative health outcomes, indicating that the company's portfolio delivers substantial health benefits. The company has also demonstrated efforts in improving access to medicines by licensing a Shigella vaccine candidate to Bharat Biotech.
1
Fair Money & Economic Opportunity
0
GSK is a biopharmaceutical company focused on medicines, vaccines, and patient assistance programs.
1
The provided articles do not contain any evidence that GSK offers lending, deposit, or other consumer financial services. Therefore, KPIs related to financial products, fees, lending practices, customer financial data, debt, or financial literacy initiatives are not applicable to the company's core business. While GSK contributed to a US$1 million Healthcare Innovation Award, this is a charitable contribution for healthcare innovation, not a reinvestment in community finance or profit-sharing with underserved communities as defined by the rubric.
2
Fair Pay & Worker Respect
40
GSK reported a CEO to median employee pay ratio of 123:1 in 2024.
1
For the same year, 32% of the global employee population was covered by collective bargaining arrangements.
2
The company achieved a reportable injury rate of 0.42 per 200,000 hours worked in 2024, with zero fatalities.
3
In terms of pay equity for GSK.US in 2024, women's median hourly pay was 4.4% higher than men's, and their median bonus pay was 8.3% higher.
4
The employee engagement score was 81% favorable in 2024, and the voluntary employee turnover rate was 5.3%.
5
Fair Trade & Ethical Sourcing
0
No evidence available to assess GlaxoSmithKline on Fair Trade & Ethical Sourcing.
Honest & Fair Business
-40
GSK has an Anti-Bribery and Corruption (ABAC) policy and training program for employees.
1
However, the company faced a $20 million SEC civil penalty in 2016 for FCPA violations, stemming from an investigation initiated in 2010.
2
These violations involved improper inducements to healthcare professionals in China, with similar conduct noted in other countries, indicating gaps in the policy's coverage or enforcement in international and high-risk markets.
3
Additionally, GSK provides an integrity line for raising concerns and employees complete mandatory conduct training.
4
Kind to Animals
-70
GSK is not certified cruelty-free.
1
In 2023, the company reported 148,766 animal uses, including rodents, rabbits, pigs, dogs, poultry, fish, and non-human primates.
2
Its animal testing policy prioritizes the 3Rs (Replacement, Reduction, Refinement) to minimize animal use.
3
Animal research is conducted when physiology is similar to humans, and when alternatives are not available or required by regulatory authorities.
4
All proposed animal research is reviewed by ethical panels.
5
GSK invests in and employs non-animal models (in vitro and in silico) whenever possible, but alternatives are not always available or required by regulatory authorities.
6
The company considers public concerns about animal research and adheres to applicable laws and regulations.
7
GSK audits approved vendors that breed animals for research, and many of its sites are accredited by AAALAC International.
8
No War, No Weapons
20
GSK's technical review and supplier surveys for 2023 indicated that no 3TGs (tin, tantalum, tungsten, gold) in its products originated from conflict-affected countries or were not from recycled or scrap sources.
1
The company maintains a 3TGs Compliance Programme following OECD Guidance
2
, embedded in its Third-Party Risk Management process
3
, and monitors materials.
4
GSK has multiple contracts with the US Defense Logistics Agency and US Army Contracting Command for medical supplies
5
, including a $975.11 million contract for Sotrovimab in January 2022
6
and a $342 million contract for COVID-19 vaccines in July 2020.
7
Additionally, GSK and ViiV Healthcare jointly pledged £6 million to the Global Fund to Fight AIDS, Tuberculosis and Malaria.
8
Planet-Friendly Business
-40
GSK's net-zero target for 2045 has been approved by the Science Based Target initiative (SBTi)
1
, with an interim goal of an 80% absolute reduction in greenhouse gas emissions across all scopes by 2030 from a 2020 baseline
2
. The company achieved 73% renewable electricity in 2022, an increase from 45% in 2020
3
, and aims for 100% by 2025
4
. In terms of compliance, GSK settled a hazardous waste violation with the EPA for $317,550 in 2014, related to issues discovered in 2012
5
. However, Pennsylvania DEP inspections have not uncovered any waste management problems in recent years
6
.
Respect for Cultures & Communities
0
No specific, quantitative evidence was found in the provided articles for any of the KPIs related to 'Respect for Cultures & Communities'. The articles discuss GSK's general inclusion efforts, employee engagement, and clinical trial diversity, but do not provide data on formal partnerships, community reinvestment, cultural incidents, local employment, grievance mechanisms, or other specific metrics outlined in the rubric. 81% of employees had favorable sentiment on inclusion in the 2024 employee survey.
1
88% of Phase III trials completing enrolment in 2024 met enrolment thresholds to represent disease epidemiology.
2
Safe & Smart Tech
0
The provided articles offer limited and outdated information regarding GSK's performance against the 'Safe & Smart Tech' ethical value. Article 1 details an alleged trade secret theft by former researchers involving 16 emails of confidential files, starting in 2012.
1
This incident falls outside the recent timeframes specified by the rubric for data breaches and unauthorized data use. Article 2, a vendor risk assessment, explicitly states it does not contain specific data on GSK's security posture.
2
Consequently, there is insufficient recent and company-specific evidence to score any of the KPIs in the rubric.
Zero Waste & Sustainable Products
-10
GSK achieved a 99.58% waste diversion rate from landfill in 2024, with only 0.2 thousand tonnes of routine waste sent to landfill out of 47.3 thousand tonnes generated.
1
The company also diverted 98.94% of its hazardous waste from landfill in 2024, with 0.2 thousand tonnes sent to landfill out of 18.9 thousand tonnes generated.
2
In 2024, 93% of paper packaging was derived from certified sources or recycled raw materials, and 100% of GSK sites now manufacture PVC-free secondary and tertiary packaging.
3
From 2024, all newly developed or acquired medicines will have Sustainable Design Plans applied, integrating environmental considerations from design to disposal.
4
GSK has implemented at least six waste reduction initiatives, contributing to a 25% operational waste reduction since 2020.
5
The company has set ambitious 2030 targets, including zero operational waste (a 20% reduction), a 10% reduction in supply chain waste, and a 25% reduction in the environmental impact of products and packaging.
6
A Sustainable Procurement Program requires suppliers to act on waste management.
7
However, GSK incurred an environmental fine of £7.9 thousand in 2024.
8